热门资讯> 正文
InflaRx GAAP每股收益为-0.13欧元
2025-05-07 19:37
- InflaRx press release (NASDAQ:IFRX): Q1 GAAP EPS of -€0.13.
- As of March 31, 2025, our total funds available amounted to approximately €65.7 million, comprised of €47.3 million of cash and cash equivalents and €18.4 million of marketable securities.
- Net cash used in operating activities decreased to €14.0 million in the three months ended March 31, 2025, from €14.9 million in the three months ended March 31, 2024.
More on InflaRx
- InflaRx dips 16%, prices $30M stock offering
- InflaRx commences offering of ordinary shares and pre-funded warrants
- Seeking Alpha’s Quant Rating on InflaRx
- Historical earnings data for InflaRx
- Financial information for InflaRx
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
